171228-49-2 98%

Globela has been forefront of innovation for nearly Seventeen years. From humble beginnings in 2006 as small pharmaceutical company, Globela’s current portfolio of vertically aligned businesses is today focused on various therapeutic areas of Gastroenterology, Cardiovascular, Diabetology, Oncology, Pain management, Nephrology and more. A EU GMP, WHO GMP, ISO Certified, MNC Accredited company, Globela also boasts of advanced research and development capability, at high quality standards complying manufacture facilities at wide range of Finished Dosage Formulations, DC Granules and Pellets (semi-finished), APIs and Intermediates. We as committed to achieving greater value for patients innovation and continuous improvement across our core businesses.